| Product Code: ETC9614901 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Blockbuster Oncology Brands Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Blockbuster Oncology Brands Market - Industry Life Cycle |
3.4 Taiwan Blockbuster Oncology Brands Market - Porter's Five Forces |
3.5 Taiwan Blockbuster Oncology Brands Market Revenues & Volume Share, By Brands, 2021 & 2031F |
3.6 Taiwan Blockbuster Oncology Brands Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Taiwan Blockbuster Oncology Brands Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Taiwan |
4.2.2 Technological advancements in oncology treatment |
4.2.3 Growing investments in research and development for oncology drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory processes for drug approval |
4.3.2 High competition from generic oncology drugs |
4.3.3 Pricing pressures in the oncology market |
5 Taiwan Blockbuster Oncology Brands Market Trends |
6 Taiwan Blockbuster Oncology Brands Market, By Types |
6.1 Taiwan Blockbuster Oncology Brands Market, By Brands |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Brands, 2021- 2031F |
6.1.3 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.1.4 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Keytruda, 2021- 2031F |
6.1.5 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Perjeta, 2021- 2031F |
6.1.6 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Ibrance, 2021- 2031F |
6.1.7 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Tecentriq, 2021- 2031F |
6.1.8 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Gazyva, 2021- 2031F |
6.1.9 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.1.10 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.2 Taiwan Blockbuster Oncology Brands Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.2.3 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.2.4 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Multiple myeloma, 2021- 2031F |
6.2.5 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.6 Taiwan Blockbuster Oncology Brands Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Blockbuster Oncology Brands Market Import-Export Trade Statistics |
7.1 Taiwan Blockbuster Oncology Brands Market Export to Major Countries |
7.2 Taiwan Blockbuster Oncology Brands Market Imports from Major Countries |
8 Taiwan Blockbuster Oncology Brands Market Key Performance Indicators |
8.1 Time to market for new oncology drug launches |
8.2 Adoption rate of innovative oncology treatments in Taiwan |
8.3 Number of clinical trials conducted for oncology drugs in Taiwan |
9 Taiwan Blockbuster Oncology Brands Market - Opportunity Assessment |
9.1 Taiwan Blockbuster Oncology Brands Market Opportunity Assessment, By Brands, 2021 & 2031F |
9.2 Taiwan Blockbuster Oncology Brands Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Taiwan Blockbuster Oncology Brands Market - Competitive Landscape |
10.1 Taiwan Blockbuster Oncology Brands Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Blockbuster Oncology Brands Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here